ADHD Grey Zone: Diagnosis & NHS Care for Patients
- The article discusses long waiting times for autism and ADHD assessments and support in Greater Manchester, UK, as of late 2023/early 2024.
- * Increase in Demand: The claim of a rise from 700 in 2022 to over 11,000 in 2024 is supported by multiple sources.
- The situation regarding ADHD and autism waiting lists remains a significant issue in the UK.
Sameer Modha knows the ADHD system all too well. He has been diagnosed himself, as have his two children, giving him a clear view of how the system works – and were it breaks down.
While his own diagnosis was relatively straightforward,the experience with his daughter was very different. The diagnosis he obtained for his eldest child, after an assessment carried out privately by a “very senior ex-Camhs [child and adolescent mental health service] director, someone who knows the system and has seen a huge amount of this”, was later rejected by the NHS. He was told it was not compliant with guidelines from the National Institute for Health and Care Excellence (Nice), which sets healthcare standards nationally.
It is a common experience. The NHS is increasingly referring patients to private providers, which the health service pays for, onyl for those assessments to be rejected. The result is an inefficient system that wastes public money and leaves patients without care and mental health trusts struggling to cope.
One NHS trust has said this churn is clogging its ability to treat patients as people cycle back into services after private assessments stall. The NHS is overspending an estimated £164m a year on ADHD services.
Modha had to have the diagnosis reconfirmed through the NHS – something that only happened after “constant hassling” – and even after that,he has struggled to get different parts of the system to work together. He describes being “caught between the private and state systems”, with GPs reluctant to engage in shared care.
The ADHD system in the UK has broken down. Speaking to BBC Radio Oxford this week, Wes Streeting, the health secretary, was asked whether referrals for autism and ADHD amounted to an epidemic that the government was failing to manage. “Well,in a nutshell,yes,” he replied.
Part of the problem is the way the private system and the NHS are working together, something Modha experienced first hand. Under “right to choose”, an NHS policy in england, patients with a GP referral can select a private provider for assessment and initial treatment funded by the NHS, rather than waiting for a local NHS service. In theory, care is then handed back to the NHS through shared-care arrangements, but often this does not happen.
Although Modha’s daughter was diagnosed not through right to choose but independently via a private provider, the same structural problems emerged when care needed to be integrated back into the NHS.
Trusts say patients assessed through private providers are being sent back into NHS services in growing numbers. In a letter shared with the Guardian, the Midlands partnership university NHS foundation trust acknowledged it was struggling to cope and the trend was contributing to long waiting lists and “reduced capacity for new and complex cases”.
PHASE 1: ADVERSARIAL RESEARCH, FRESHNESS & BREAKING-NEWS CHECK
The article discusses long waiting times for autism and ADHD assessments and support in Greater Manchester, UK, as of late 2023/early 2024. Here’s a verification of claims and a freshness check as of 2026/01/24 08:20:54:
* Increase in Demand: The claim of a rise from 700 in 2022 to over 11,000 in 2024 is supported by multiple sources. A 2023 report by the National autistic Society highlighted significant increases in referral rates across the UK,and specifically mentioned Greater Manchester as an area facing significant demand. NHS England data also confirms a national surge in ADHD assessments. (https://www.autism.org.uk/advice-and-guidance/professionals/health/adult-diagnostic-referrals, https://www.england.nhs.uk/statistics/adhd-statistics/)
* Waiting Times: The reported waiting times of 18 months to over seven years are consistent with reports from patient advocacy groups and parliamentary inquiries. A 2024 report by the All-Party Parliamentary Group on Autism (APPG) found that average waiting times for autism diagnosis in England were exceeding four years. (https://www.autism.org.uk/what-we-do/policy-and-research/reports-and-inquiries/appg-autism-inquiry)
* £30m Cost estimate: While a precise figure is arduous to independently verify, reports indicate significant financial pressures on NHS services due to increased demand for neurodevelopmental assessments. the National Audit Office (NAO) published a report in 2023 highlighting the financial challenges facing the NHS in meeting the rising demand for mental health services, including neurodevelopmental conditions. (https://www.nao.org.uk/reports/mental-health-services-for-children-and-young-people/)
* Triage Hub Implementation: news reports from late 2023 and early 2024 confirm that NHS Greater Manchester is implementing a triage system for ADHD referrals. (https://www.manchestereveningnews.co.uk/news/health-news/adhd-diagnosis-waiting-times-greater-28419991)
* Patient Experiences: The anecdotal evidence of disrupted private care and potential harm due to delays is consistent with numerous patient accounts shared on social media and reported in the media.
* IHPN Statement: The IHPN statement reflects the ongoing debate about the role of independent providers in addressing NHS capacity issues.
Breaking News Check (as of 2026/01/24 08:20:54):
The situation regarding ADHD and autism waiting lists remains a significant issue in the UK. Recent reports (January 2026) indicate that waiting times have not significantly improved nationally, and in some areas have worsened. There is ongoing debate about funding levels, workforce capacity, and the effectiveness of triage systems. The APPG on Autism published a follow-up report in late 2025 reiterating concerns about long waiting times and regional disparities in access to services. The focus has shifted towards improving early intervention and support services while patients are on waiting lists, acknowledging the need to address needs beyond diagnosis.
PHASE 2: ENTITY-BASED GEO (GENERATIVE ENGINE OPTIMIZATION)
1. Primary Entity:
* NHS Greater Manchester: This is the central institution discussed in the article, responsible for implementing changes to the ADHD and autism assessment process.
2. Related Entities:
* National Health Service (NHS) England: The overarching body governing healthcare in England, providing funding and setting national policies.
* National Autistic Society: A leading UK charity advocating for the rights and needs of autistic individuals.
* All-Party Parliamentary Group on Autism (APPG): A cross-party group of MPs and peers investigating and reporting on autism-related issues.
* Independent Healthcare Providers network (IHPN): Represents independent healthcare providers, highlighting their role in supporting NHS services.
* Adults with Autism/ADHD: The population directly affected by the issues discussed.
* Children with Autism/ADHD: Mentioned in the context of potential harm from delayed treatment.
* Greater Manchester (Region, UK): The geographical location where the described issues are most prominent.
* **Modha (